THROMBOCYTHEMIA, ESSENTIAL
Clinical trials for THROMBOCYTHEMIA, ESSENTIAL explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear
Sign up with your email to follow new studies for THROMBOCYTHEMIA, ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer patients continue experimental drug in Long-Term safety hunt
Disease control Recruiting nowThis study allows patients who are already taking the experimental drug bomedemstat for certain rare blood cancers to continue treatment in a long-term follow-up study. The main goal is to collect more information about the drug's safety and how well it continues to work over a l…
Matched conditions: THROMBOCYTHEMIA, ESSENTIAL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study designed to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. for 5-10 years, collecting health records and patient surveys to track symptoms, treatm…
Matched conditions: THROMBOCYTHEMIA, ESSENTIAL
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC